344 related articles for article (PubMed ID: 34091065)
21. Evidence-Based Therapies for Pharmacologic Prevention and Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism.
Jacobs B; Henke PK
Surg Clin North Am; 2018 Apr; 98(2):239-253. PubMed ID: 29502769
[TBL] [Abstract][Full Text] [Related]
22. Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice.
McGarry LJ; Thompson D
Clin Ther; 2004 Mar; 26(3):419-30. PubMed ID: 15110135
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems.
Pillai P; Joseph JP; Fadzillah NHM; Mahmod M
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105427. PubMed ID: 33137615
[TBL] [Abstract][Full Text] [Related]
24. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.
Daughety MM; Morgan A; Frost E; Kao C; Hwang J; Tobin R; Patel B; Fuller M; Welsby I; Ortel TL
Thromb Res; 2020 Dec; 196():483-485. PubMed ID: 33091700
[TBL] [Abstract][Full Text] [Related]
26. Elevated risk of venous thromboembolic events in patients with inflammatory myopathies.
Nowak M; Królak-Nowak K; Sobolewska-Włodarczyk A; Fichna J; Włodarczyk M
Vasc Health Risk Manag; 2016; 12():233-8. PubMed ID: 27350751
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism: "... an ounce of prevention is worth a pound of cure".
Goldhaber SZ; Ageno W
Thromb Haemost; 2015 Jun; 113(6):1174-5. PubMed ID: 25947622
[No Abstract] [Full Text] [Related]
28. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Venous Thromboembolism after Total Knee Arthroplasty Using Dielectric Blood Coagulometry.
Uchiyama H; Inoue Y; Uchimura I; Nakamura T; Kudo T; Muneta T; Kawano T
Ann Vasc Surg; 2017 Jan; 38():286-292. PubMed ID: 27522973
[TBL] [Abstract][Full Text] [Related]
30. [Introduction. Venous thromboembolism in cancer patients].
Martínez del Prado P
Med Clin (Barc); 2015 Jan; 144 Suppl 1():1-2. PubMed ID: 25771085
[No Abstract] [Full Text] [Related]
31. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.
Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K
Br J Haematol; 2020 Aug; 190(4):529-532. PubMed ID: 32621757
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach.
Black SA; Cohen AT
Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864
[TBL] [Abstract][Full Text] [Related]
33. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
Choi JJ; Wehmeyer GT; Li HA; Alshak MN; Nahid M; Rajan M; Liu B; Schatoff EM; Elahjji R; Abdelghany Y; D'Angelo D; Crossman D; Evans AT; Steel P; Pinheiro LC; Goyal P; Safford MM; Mints G; DeSancho MT
Thromb Res; 2020 Dec; 196():318-321. PubMed ID: 32977130
[No Abstract] [Full Text] [Related]
34. Management of venous thromboembolism.
Burnett B
Prim Care; 2013 Mar; 40(1):73-90. PubMed ID: 23402462
[TBL] [Abstract][Full Text] [Related]
35. Direct oral anticoagulants and venous thromboembolism.
Franchini M; Mannucci PM
Eur Respir Rev; 2016 Sep; 25(141):295-302. PubMed ID: 27581829
[TBL] [Abstract][Full Text] [Related]
36. Prevention of venous thromboembolism through the implementation of a risk assessment tool: a comparative study in medical and surgical patients.
Park MY; Fletcher JP; Hoffmann C; Lance A; Gavegan F; Hitos K
Int Angiol; 2018 Oct; 37(5):411-418. PubMed ID: 29463079
[TBL] [Abstract][Full Text] [Related]
37. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients.
Granziera S; Cohen AT
Thromb Haemost; 2015 Jun; 113(6):1216-23. PubMed ID: 25809340
[TBL] [Abstract][Full Text] [Related]
38. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
39. Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19.
Varasteh Kia M; Lau BD; Owodunni OP; Kraus PS; Holzmueller CG; Hobson DB; Shaffer DL; Streiff MB; Haut ER
J Thromb Thrombolysis; 2021 Aug; 52(2):471-475. PubMed ID: 33507453
[TBL] [Abstract][Full Text] [Related]
40. Thromboprophylaxis in nonsurgical patients.
Streiff MB; Lau BD
Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
